Back
Salesforce Vs. Kymera Therapeutics Industry Stock Comparison
Buy
54
CRM
Salesforce
Last Price:
$273.75
Seasonality Move:
8.88%
Buy
70
KYMR
Kymera Therapeutics
Last Price:
$43.43
Seasonality Move:
5.78%
Buy
54
Salesforce (CRM)
is a Buy
Is Salesforce a Buy, Sell or Hold?
-
The current Salesforce [CRM] share price is $269.80. The Score for CRM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
CRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRM Stock Price Chart
What is Salesforce's stock price today?
-
The Salesforce share price today is $269.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRM is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $44.79The current trend is moderately bearish and KYMR is experiencing slight buying pressure.
CRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.1 | Buy |
Relative Strength Index (14 RSI): | 50.4 | Buy |
Chaikin Money Flow: | -2834683 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (262.52 - 271.64) | Buy |
Bollinger Bands (100): | (256.72 - 297.9) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 58.43 | Buy |
Chaikin Money Flow: | 47554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 270.96 | Sell |
20-day SMA: | 267.76 | Buy |
50-day SMA: | 272.42 | Sell |
200-day SMA: | 296.57 | Sell |
8-day EMA: | 270.13 | Sell |
20-day EMA: | 269.1 | Buy |
50-day EMA: | 255.54 | Buy |
200-day EMA: | 140.7 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.11 | Sell |
20-day SMA: | 46.32 | Sell |
50-day SMA: | 38 | Buy |
200-day SMA: | 39.54 | Buy |
8-day EMA: | 44.94 | Sell |
20-day EMA: | 44.02 | Buy |
50-day EMA: | 39.8 | Buy |
200-day EMA: | 37.62 | Buy |
Salesforce Earnings Growth & CRM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $0.23 per share, an increase this year of $1.83 per share, and an increase next year of $1.26 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.
Salesforce Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |